This is the jumping-off point for all TLS drug development projects. From here, you'll be able to access Project Dashboards for each drug candidate, where you'll have the opportunity to provide high-level input via TLS Protocol Builders (short questionaires that survey the central ideas of the protocol.) Or, if you prefer, you may add your ideas and comment on the ideas of others directly within in the protocol synopses themselves.
|
NEW -- Indication Finder™: A Repurposing Hunt. In keeping with our commitment to crowdsourcing and transparency, we invite you to participate in a unique exercise. The U.S. National Center for Advancing Translational Sciences (NCATS) has posted a list of 58 compounds that are available for repurposing studies. We need your help to determine if some of these compounds might be good candidates for our open innovation approach to drug development. Intrigued? Click here to find out more! |
| Name | Last Updated | Progress |
|---|---|---|
| Low-Dose Naltrexone ("LDN") in Crohn's | May 2013 |  |
| Name | Last Updated | Progress |
|---|---|---|
| Lisinopril in Multiple Sclerosis | May 2013 |  |
| Name | Last Updated | Progress |
|---|---|---|
| PPAR in Parkinson's Disease | May 2013 |  |
Researchers & PhysiciansLearn how to apply your professional knowledge to open protocol design.
Patients and FamiliesLearn more about how patients can impact TLS's process.
